Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients
Latest Information Update: 29 Apr 2015
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 20 Apr 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Jun 2016 as per ClinicalTrials.gov record.
- 04 Dec 2013 New trial record